Dimensional Fund Advisors LP Provention Bio, Inc. Transaction History

Dimensional Fund Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$6.7 - $24.21 $11,162 - $40,333	1,666 Added 2.19%	77,775 $1.87 Million
Q4 2022 Feb 09, 2023	SELL	$4.52 - $10.57 $2,133 - $4,989	-472 Reduced 0.62%	76,109 $804,000
Q3 2022 Nov 10, 2022	SELL	$3.43 - $5.62 $11,871 - $19,450	-3,461 Reduced 4.32%	76,581 $344,000
Q2 2022 Aug 12, 2022	BUY	$3.65 - $7.3 $174,875 - $349,750	47,911 Added 149.11%	80,042 $320,000
Q4 2021 Feb 09, 2022	BUY	$5.59 - $7.39 $179,612 - $237,448	32,131 New	32,131 $181,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.